Institutional & Family Asset Management »

Sab Biotherapeutics shares owned by Institutional & Family Asset Management

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Institutional & Family Asset Management from 13F filings

Historical chart of Institutional & Family Asset Management investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Institutional & Family Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Institutional & Family Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $87k 19k 4.54

More positions owned by Institutional & Family Asset Management

Ishares Tr Core Msci Eafe (IEFA)
Listed Fd Tr Core Alt Fd (CCOR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr U.s. Real Es Etf (IYR)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Apple (AAPL)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Ishares Tr Iboxx Inv Cp Etf (LQD)

View all positions for Institutional & Family Asset Management

Top funds holding Sab Biotherapeutics

BVF
Marshall Wace
Sessa Capital IM
Commodore Capital
Vanguard Group
Geode Capital Management
Millennium Management
Pathstone Holdings
First Manhattan
Institutional & Family Asset Management
BlackRock
Advisor Group Holdings
Tower Research Capital
Morgan Stanley
Spectrum Wealth Counsel

View all funds holding Sab Biotherapeutics